Showing results (661-670 of 16,156) with videos related to

Sort By:
Pageof 1,616
European Journal of Medicinal Chemistry|December 22, 2019
Synthesis and anti-cancer activity studies of dammarane-type triterpenoid derivativesLu Ma, Xude Wang, Wei Li, et al.
European Journal of Medicinal Chemistry|December 23, 2019
Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's diseaseZhipei Sang, Keren Wang, Jian Shi, et al.
European Journal of Medicinal Chemistry|December 23, 2019
Development of cell-permeable peptide-based PROTACs targeting estrogen receptor αYuxuan Dai, Na Yue, Junni Gong, et al.
European Journal of Medicinal Chemistry|November 23, 2019
Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agentsDaniel Szulczyk, Anna Bielenica, Agnieszka Głogowska, et al.
European Journal of Medicinal Chemistry|November 27, 2019
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activitiesTing Xiao, Jia-Fan Tang, Ge Meng, et al.
European Journal of Medicinal Chemistry|December 6, 2019
Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitorsYinhu Wang, Rawaf Alenzy, Di Song, et al.
European Journal of Medicinal Chemistry|February 17, 2020
Therapeutic potential of targeting SHP2 in human developmental disorders and cancersDadong Shen, Wenxia Chen, Jinlin Zhu, et al.
European Journal of Medicinal Chemistry|February 21, 2020
Design, synthesis and evaluation of phenylthiazole and phenylthiophene pyrimidindiamine derivatives targeting the bacterial membraneTingting Fan, Weikai Guo, Ting Shao, et al.
European Journal of Medicinal Chemistry|February 24, 2020
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitorsNing-Yu Wang, Ying Xu, Kun-Jie Xiao, et al.
Pageof 1,616